AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) has announced its participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference to be held in Toronto on April 25, 2023. The presentation is scheduled for 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time). A live audio webcast of the event will be available on AbCellera's Investor Relations website, with a replay accessible after the presentation.

AbCellera is pioneering advancements in antibody drug discovery, aiming to deliver superior medicines to patients faster. The company's integrated approach combines expert teams and innovative technology to streamline the drug development process, offering significant advantages to biotech firms and pharmaceutical companies.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference in Toronto on Tuesday, April 25, 2023, at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner. AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005772/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera presenting at the 2023 Bloom Burton & Co. Healthcare Investor Conference?

AbCellera will present on April 25, 2023, at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).

How can I access the live presentation of AbCellera at the conference?

The live audio webcast can be accessed through AbCellera's Investor Relations website.

What is the focus of AbCellera in the biotechnology sector?

AbCellera focuses on innovating antibody drug discovery to enhance the speed and efficacy of bringing medicines to patients.

What are the key benefits of AbCellera's approach to drug development?

AbCellera’s integrated system provides a competitive edge, allowing companies to reduce costs and address complex drug development challenges.

What is the stock symbol for AbCellera?

AbCellera's stock symbol is ABCL.